The effect of impaired glucose metabolism on weight loss in multidisciplinary childhood obesity treatment

Autor: Jesper Johannesen, Cilius Esmann Fonvig, Torben Hansen, Oluf Pedersen, Tenna Ruest Haarmark Nielsen, Michael Gamborg, Jens-Christian Holm, Julie T. Kloppenborg
Rok vydání: 2017
Předmět:
Blood Glucose
Male
medicine.medical_specialty
Pediatric Obesity
Prediabetic State/blood
Adolescent
Glycated Hemoglobin A/metabolism
Endocrinology
Diabetes and Metabolism

medicine.medical_treatment
Physiology
030209 endocrinology & metabolism
Overweight
Childhood obesity
Body Mass Index
Prediabetic State
03 medical and health sciences
Young Adult
0302 clinical medicine
Weight loss
Internal medicine
Glucose Intolerance
Weight Loss
Internal Medicine
medicine
Humans
Insulin
030212 general & internal medicine
Prediabetes
Longitudinal Studies
Child
Glucose Intolerance/blood
Weight Reduction Programs/statistics & numerical data
Glycated Hemoglobin
C-Peptide
business.industry
medicine.disease
Obesity
Pediatric Obesity/blood
Weight Reduction Programs
Endocrinology
Pediatrics
Perinatology and Child Health

C-Peptide/blood
Median body
Female
medicine.symptom
business
Insulin/blood
Body mass index
Zdroj: Kloppenborg, J T, Gamborg, M, Fonvig, C E, Nielsen, T R H, Pedersen, O, Johannesen, J, Hansen, T & Holm, J-C 2018, ' The effect of impaired glucose metabolism on weight loss in multidisciplinary childhood obesity treatment ', Pediatric Diabetes, vol. 19, no. 3, pp. 366-374 . https://doi.org/10.1111/pedi.12605
ISSN: 1399-5448
DOI: 10.1111/pedi.12605
Popis: OBJECTIVE: To investigate whether children and adolescents exhibiting an impaired glucose metabolism are more obese at treatment entry and less likely to reduce their degree of obesity during treatment.METHODS: The present study is a longitudinal observational study, including children and adolescents from the Children's Obesity Clinic, Holbaek, Denmark. Anthropometrics, pubertal development, socioeconomic status (SES), and fasting concentrations of plasma glucose, serum insulin, serum C-peptide, and whole blood glycosylated hemoglobin (HbA1c) were collected at treatment entry and at follow-up. Proxies of Homeostasis Model Assessment 2-insulin sensitivity (HOMA2-IS) and Homeostasis Model Assessment 2-β-cell function (HOMA2-B) were calculated with the Homeostasis Model Assessment 2 program.RESULTS: In total, 569 (333 boys) patients, median 11.5 years of age (range 6-22 years), and median body mass index (BMI) z-score 2.94 (range 1.34-5.54) were included. The mean BMI z-score reduction was 0.31 (±0.46) after 13 months (range 6-18) of treatment. At treatment entry, patients with impaired estimates of glucose metabolism were more obese than normoglycemic patients. Baseline concentration of C-peptide was associated with a lower weight loss during treatment in girls (P = .02). Reduction in the insulin concentrations was associated with reduction in BMI z-score in both sexes (P CONCLUSION: The capability to reduce weight during multidisciplinary treatment in children and adolescents with overweight/obesity is not influenced by an impaired glucose metabolism at study entry or during the course of treatment.
Databáze: OpenAIRE